Equity Analysis

Company Profile

Balance Sheet

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

16.3727599

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

163.33

27.34

EPS(TTM)

Face Value()

Div & Yield %:

0.12

Particulars (Sources Of Funds)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Share Capital	13.95	9.95	3.30	3.30	3.30
Reserves Total	8.89	0.73	4.10	4.06	3.94
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	22.84	10.68	7.40	7.36	7.24
Secured Loans	6.83	4.93	5.30	5.52	4.53
Unsecured Loans	0.00	0.00	0.00	0.00	0.00
Total Debt	6.83	4.93	5.30	5.52	4.53
Other Liabilities	0.00	0.00	0.00	0.00	0.00
Total Liabilities	29.67	15.61	12.70	12.88	11.77
APPLICATION OF FUNDS :
Gross Block	9.39	9.38	9.36	1.87	2.13
Less : Accumulated Depreciation	8.00	7.87	7.71	0.00	0.00
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00
Net Block	1.39	1.51	1.65	1.87	2.13
Lease Adjustment	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances
Inventories	4.47	0.88	2.28	2.06	2.11
Sundry Debtors	5.68	5.60	7.79	7.65	7.27
Cash and Bank Balance	6.05	0.03	0.04	0.05	0.07
Loans and Advances	2.41	1.54	1.80	2.22	2.39
Total Current Assets	18.62	8.05	11.91	11.97	11.83
Less : Current Liabilities and Provisions
Current Liabilities	2.07	1.45	0.78	0.90	2.11
Provisions	0.58	0.54	0.03	0.06	0.07
Total Current Liabilities & Provisions	2.65	2.00	0.80	0.95	2.17
Net Current Assets	15.96	6.06	11.11	11.02	9.66
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.08	0.07	0.06	0.06	0.06
Net Deferred Tax	-0.08	-0.07	-0.06	-0.06	-0.06
Other Assets	12.41	8.11	0.00	0.05	0.05
Total Assets	29.67	15.61	12.70	12.88	11.78
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00